Clinical Trial Update: Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials have completed evaluating the safety and immunogenicity of Sinovac's Sabin Inactivated Poliovirus Vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Poliomyelitis

Drugs mentioned

• Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Poliomyelitis | Phase 1, Phase 2 | Status: COMPLETED